- Home
- TARS vs HLIO Comparison
TARS vs HLIO Comparison
Compare TARS & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- HLIO
- Stock Information
- Founded
- TARS 2016
- HLIO 1970
- Country
- TARS United States
- HLIO United States
- Employees
- TARS N/A
- HLIO N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- HLIO Metal Fabrications
- Sector
- TARS Health Care
- HLIO Industrials
- Exchange
- TARS Nasdaq
- HLIO Nasdaq
- Market Cap
- TARS 1.7B
- HLIO 1.8B
- IPO Year
- TARS 2020
- HLIO N/A
- Fundamental
- Price
- TARS $51.69
- HLIO $53.62
- Analyst Decision
- TARS Strong Buy
- HLIO Strong Buy
- Analyst Count
- TARS 7
- HLIO 5
- Target Price
- TARS $67.14
- HLIO $47.60
- AVG Volume (30 Days)
- TARS 679.4K
- HLIO 244.5K
- Earning Date
- TARS 11-12-2025
- HLIO 11-04-2025
- Dividend Yield
- TARS N/A
- HLIO 0.67%
- EPS Growth
- TARS N/A
- HLIO 17.55
- EPS
- TARS N/A
- HLIO 1.05
- Revenue
- TARS $295,521,000.00
- HLIO $782,000,000.00
- Revenue This Year
- TARS $33,170.29
- HLIO $3.91
- Revenue Next Year
- TARS N/A
- HLIO $2.54
- P/E Ratio
- TARS N/A
- HLIO $51.02
- Revenue Growth
- TARS 254.45
- HLIO N/A
- 52 Week Low
- TARS $30.23
- HLIO $24.76
- 52 Week High
- TARS $59.76
- HLIO $57.29
- Technical
- Relative Strength Index (RSI)
- TARS 46.25
- HLIO 57.21
- Support Level
- TARS $48.20
- HLIO $53.79
- Resistance Level
- TARS $59.76
- HLIO $56.10
- Average True Range (ATR)
- TARS 2.04
- HLIO 1.38
- MACD
- TARS -1.29
- HLIO -0.63
- Stochastic Oscillator
- TARS 30.19
- HLIO 39.36
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.